Legal Opinion
Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals
Court of Appeals for the Federal Circuit
Decided April 13, 2018No. 2016-2707, 2016-2708PublishedCited by 71 opinions
1Opinion of the Court
Dissenting opinion filed by Chief Judge Prost.
Lourie, Circuit Judge.
West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp. (collectively, "West-Ward") appeal from the decision of the United States District Court for the District of Delaware holding, after a bench trial, claims 1-9, 11-13, and 16 ("the asserted claims") of U.S. Patent 8,586,610 ("the '610 patent") infringed and not invalid. See Vanda Pharm. Inc. v. Roxane Labs., Inc. , 203 F.Supp.3d 412 (D. Del. 2016) (" Opinion "). For the following reasons, we affirm.
BACKGROUND
I
Aventisub LLC ("Aventisub") owns…
2Cases cited47 opinions
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Singleton v. WulffSupreme Court of the United States · 1976
- Gross v. FBL Financial Services, Inc.Supreme Court of the United States · 2009
- Arizonans for Official English v. ArizonaSupreme Court of the United States · 1997
42 more not listed; retrieve them via the Exa API.
3Cited by71 opinions
- Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLCCourt of Appeals for the Federal Circuit · 2019
- Barry v. Medtronic, Inc.Court of Appeals for the Federal Circuit · 2019
- Genetic Veterinary Sciences v. Laboklin Gmbh & Co. KgCourt of Appeals for the Federal Circuit · 2019
- Natural Alternatives Int'l, Inc. v. Creative Compounds, LLCCourt of Appeals for the Federal Circuit · 2019
- Sionyx, LLC v. Hamamatsu Photonics K.K.District Court, District of Columbia · 2018
66 more not listed; retrieve them via the Exa API.